ArticleJournal of diabetes investigation2024

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan.

Ryo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.